STOCK TITAN

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Avadel Pharmaceuticals (Nasdaq: AVDL) has announced its upcoming participation in the Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET. Interested parties can access a live webcast of the discussion through Avadel's Investor Relations website at investors.avadel.com, where the recording will remain available for 90 days after the conference.

Avadel Pharmaceuticals (Nasdaq: AVDL) ha annunciato la sua prossima partecipazione al Jefferies London Healthcare Conference. Il management dell'azienda parteciperà a una chiacchierata informale mercoledì 20 novembre alle 7:30 GMT / 2:30 ET. Le parti interessate possono accedere a una diretta web della discussione attraverso il sito web delle Relazioni con gli Investitori di Avadel all'indirizzo investors.avadel.com, dove la registrazione rimarrà disponibile per 90 giorni dopo la conferenza.

Avadel Pharmaceuticals (Nasdaq: AVDL) ha anunciado su próxima participación en la Conferencia de Salud de Jefferies en Londres. La dirección de la empresa participará en una charla informal el miércoles 20 de noviembre a las 7:30 a.m. GMT / 2:30 a.m. ET. Las partes interesadas pueden acceder a una transmisión en vivo de la discusión a través del sitio web de Relaciones con Inversores de Avadel en investors.avadel.com, donde la grabación estará disponible durante 90 días después de la conferencia.

Avadel Pharmaceuticals (Nasdaq: AVDL)는 제퍼리즈 런던 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 경영진은 11월 20일 수요일 GMT 오전 7:30 / ET 오전 2:30에 화상 대화에 참여할 것입니다. 관심 있는 분들은 Avadel의 투자자 관계 웹사이트인 investors.avadel.com를 통해 논의의 라이브 웹캐스트에 접속할 수 있으며, 회의 종료 후 90일 동안 녹화본을 이용할 수 있습니다.

Avadel Pharmaceuticals (Nasdaq: AVDL) a annoncé sa prochaine participation à la Conférence Jefferies Healthcare de Londres. La direction de l'entreprise prendra part à une discussion informelle le mercredi 20 novembre à 7h30 GMT / 2h30 ET. Les parties intéressées peuvent accéder à un webcast en direct de la discussion via le site web des Relations Investisseurs d'Avadel à l'adresse investors.avadel.com, où l'enregistrement restera disponible pendant 90 jours après la conférence.

Avadel Pharmaceuticals (Nasdaq: AVDL) hat seine bevorstehende Teilnahme an der Jefferies London Healthcare Conference angekündigt. Das Management des Unternehmens wird am Mittwoch, den 20. November, um 7:30 Uhr GMT / 2:30 Uhr ET an einem informellen Gespräch teilnehmen. Interessierte können über die Investor Relations-Website von Avadel unter investors.avadel.com auf einen Live-Stream der Diskussion zugreifen, wo die Aufzeichnung 90 Tage nach der Konferenz verfügbar bleibt.

Positive
  • None.
Negative
  • None.

DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc 

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZTM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com

Investor Contact:
Courtney Mogerley
Precision AQ
Courtney.Mogerley@precisionAQ.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162


FAQ

When is Avadel Pharmaceuticals (AVDL) presenting at the Jefferies London Healthcare Conference?

Avadel Pharmaceuticals will present on Wednesday, November 20 at 7:30 a.m. GMT / 2:30 a.m. ET.

How can I watch Avadel Pharmaceuticals' (AVDL) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast on Avadel's Investor Relations website at investors.avadel.com.

How long will Avadel Pharmaceuticals' (AVDL) Jefferies Conference presentation be available online?

The recorded presentation will be available on Avadel's Investor Relations website for 90 days following the conference.

What type of presentation will Avadel Pharmaceuticals (AVDL) give at the Jefferies Conference?

Avadel Pharmaceuticals' management will participate in a fireside chat format presentation.

Avadel Pharmaceuticals plc Ordinary Share

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Stock Data

1.13B
96.36M
4.77%
80%
10.58%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN